Revvity (RVTY) Cash from Financing Activities (2009 - 2026)
Revvity (RVTY) posted Cash from Financing Activities of -$88.9 million for Q2 2026, up 49.58% quarter-over-quarter from -$176.3 million in Q4 2025, and up 45.68% year-on-year from -$61.0 million in Q2 2025.
Revvity (RVTY) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Revvity (RVTY) has reported Cash from Financing Activities for 18 consecutive years, with -$88.9 million the latest figure, recorded in Q2 2026.
- Cash from Financing Activities for Q2 2026 came in at -$88.9 million, up 45.68% year-over-year; the trailing twelve-month figure through Apr 2026 was -$782.8 million (up 37.72% YoY), and the FY2025 annual result was -$857.5 million, up 23.99% from the prior year.
- Cash from Financing Activities was -$88.9 million for Q2 2026 at Revvity, up from -$176.3 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at -$19.6 million in Q4 2023 and troughed at -$3.7 billion in Q1 2023.
- Average Cash from Financing Activities over 5 years is -$461.9 million, with a median of -$176.3 million recorded in 2025.
- Year-over-year, Cash from Financing Activities surged 99.48% in 2023 and slumped 1041.63% in 2025.
- Over 5 years, Cash from Financing Activities stood at -$164.9 million in 2022, then jumped by 88.1% to -$19.6 million in 2023, then tumbled by 883.94% to -$193.0 million in 2024, then gained by 8.64% to -$176.3 million in 2025, then soared by 49.58% to -$88.9 million in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were -$88.9 million in Q2 2026, -$176.3 million in Q4 2025, and -$215.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -213.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.09 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 46.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -211.43 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 3.76 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -144.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -433.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -251.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -114.33 Mn |
| 10 | Revvity | 12.62 Bn | 11.76 Bn | 387.66 Mn | -88.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | -88.90 Mn |
| Apr 5, 2026 | -88.90 Mn |
| Dec 28, 2025 | -176.31 Mn |
| Dec 28, 2025 | -176.31 Mn |
| Sep 28, 2025 | -215.07 Mn |
| Sep 28, 2025 | -215.07 Mn |
| Jun 29, 2025 | -302.48 Mn |
| Jun 29, 2025 | -302.48 Mn |
| Mar 30, 2025 | -163.66 Mn |
| Mar 30, 2025 | -163.66 Mn |
| Dec 29, 2024 | -192.99 Mn |
| Dec 29, 2024 | -192.99 Mn |
| Sep 29, 2024 | -873.74 Mn |
| Sep 29, 2024 | -873.74 Mn |
| Jun 30, 2024 | -26.50 Mn |
| Jun 30, 2024 | -26.50 Mn |
| Mar 31, 2024 | -35.01 Mn |
| Mar 31, 2024 | -35.01 Mn |
| Dec 31, 2023 | -19.61 Mn |
| Dec 31, 2023 | -19.61 Mn |